New monitor tracks blood sugar during cancer treatment
NCT ID NCT04315857
Summary
This study tested whether a continuous glucose monitor (Freestyle Libre) could help manage blood sugar in diabetic patients starting chemotherapy. Researchers wanted to see if this device could detect dangerous highs and lows in blood sugar that might affect chemotherapy safety and effectiveness. The study involved 103 diabetic cancer patients to gather information, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.